SHYRL HOAG: Open Payments
NPI 1598365108 · ANKENY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,191 in 67 payments from 16 companies in 2025. Trend: 2023 $2,019 · 2024 $2,168 · 2025 $2,191
Food & beverage: $2,183Education: $8
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $521 |
| Otsuka America Pharmaceutical, Inc. | 15 | $446 |
| Axsome Therapeutics, Inc. | 4 | $260 |
| MDD US Operations, LLC | 4 | $177 |
| E.R. Squibb & Sons, L.L.C. | 6 | $162 |
| Vanda Pharmaceuticals Inc. | 3 | $154 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $128 |
| Corium, LLC | 4 | $99 |
| Lundbeck LLC | 3 | $73 |
| Janssen Pharmaceuticals, Inc | 3 | $54 |
Products named: VRAYLAR, REXULTI, Auvelity, Qelbree, COBENFY, FANAPT, CAPLYTA, Azstarys.
Industry payments across IA — which companies pay providers there.
